Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers

References

• Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976;192:481–3
   PubMed Web of Science ®Google Scholar
• Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 2004;3:353–9
   PubMed Web of Science ®Google Scholar
• Phiel CJ, Klein PS. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001;41:789–813
   PubMed Web of Science ®Google Scholar
• Thase ME, Denko T. Pharmacotherapy of mood disorders. Annu Rev Clin Psychol 2008;4:53–91
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Marion S, Rodriguiz RM, et al. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008;132:125–36
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989;59:411–19
   PubMed Web of Science ®Google Scholar
• Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93:8455–9
   PubMed Web of Science ®Google Scholar
• Li X, Jope RS. Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 2010;35:2143–54
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Caron MG. Looking at lithium: molecular moods and complex behaviour. Mol Interv 2008;8:230–41
   PubMed Web of Science ®Google Scholar
• Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417:292–5
   PubMed Web of Science ®Google Scholar
• Phiel CJ, Zhang F, Huang EY, et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001;276:36734–41
   PubMed Web of Science ®Google Scholar
• Kuo CC, Lu L. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br J Pharmacol 1997;121:1231–8
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Sotnikova TD, Marion S, et al. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005;122:261–73
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Sotnikova TD, Yao WD, et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 2004;101:5099–104
   PubMed Web of Science ®Google Scholar
• Bohn LM, Lefkowitz RJ, Gainetdinov RR, et al. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 1999;286:2495–8
   PubMed Web of Science ®Google Scholar
• Wissocq JC, Heurteaux C, Thellier M. Estimation of local kinetic parameters of exchange of lithium in various substructures of the mouse brain, using the 6Li(n, alpha)3H-nuclear reaction. Neuropharmacology 1983;22:227–32
   PubMed Web of Science ®Google Scholar
• Gould TD, O'Donnell KC, Picchini AM, Manji HK. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 2007;32:1321–33
   PubMed Web of Science ®Google Scholar
• Ralph-Williams RJ, Paulus MP, Zhuang X, et al. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 2003;53:352–9
   PubMed Web of Science ®Google Scholar
• Rao S, Rajesh KR, Joseph T. Effect of antiepileptic drugs valproic acid, carbamazepine and ethosuccimide on exploratory behaviour in mice. Indian J Exp Biol 1991;29:127–30
   PubMed Web of Science ®Google Scholar
• Lagrue E, Chalon S, Bodard S, et al. Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice. Pediatr Res 2007;62:14–19
   PubMed Web of Science ®Google Scholar
• Calzavara MB, Medrano WA, Levin R, et al. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia? Schizophr Bull 2009;35:748–59
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J Biol Chem 2006;281:32072–80
   PubMed Web of Science ®Google Scholar
• Håkansson K, Galdi S, Hendrick J, et al. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J Neurochem 2006;96:482–8
   PubMed Web of Science ®Google Scholar
• Emamian ES, Hall D, Birnbaum MJ, et al. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004;36:131–7
   PubMed Web of Science ®Google Scholar
• Hao Y, Creson T, Zhang L, et al. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 2004;24:6590–9
   PubMed Web of Science ®Google Scholar
• Leng Y, Liang MH, Ren M, et al. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 2008;28:2576–88
   PubMed Web of Science ®Google Scholar
• Chang YC, Rapoport SI, Rao JS. Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem Res 2009;34:536–41
   PubMed Web of Science ®Google Scholar
• Ahmad S, Fowler LJ, Whitton PS. Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol 2004;142:136–42
   PubMed Web of Science ®Google Scholar
• Crowley JJ, Jones MD, O'Leary OF, Lucki I. Automated tests for measuring the effects of antidepressants in mice. Pharmacol Biochem Behav 2004;78:269–74
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Zhang X, Rodriguiz RM, et al. Role of GSK3beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 2008;105:1333–8
   PubMed Web of Science ®Google Scholar
• Weisstaub NV, Zhou M, Lira A, et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006;313:536–40
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Tirotta E, Sotnikova TD, et al. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 2007;27:881–5
   PubMed Web of Science ®Google Scholar
• Enjalbert A, Bockaert J. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 1983;23:576–84
   PubMed Web of Science ®Google Scholar
• Nishi A, Snyder GL, Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 1997;17:8147–55
   PubMed Web of Science ®Google Scholar
• Chalecka-Franaszek E, Chuang DM. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999;96:8745–50
   PubMed Web of Science ®Google Scholar
• De Sarno P, Li X, Jope RS. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 2002;43:1158–64
   PubMed Web of Science ®Google Scholar
• Gould TD, Einat H, O'Donnell KC, et al. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007;10:2173–83
   Web of Science ®Google Scholar
• Zhang Z-W, Burke MW, Calakos N, et al. Confocal analysis of cholinergic and dopaminergic inputs onto pyramidal cells in the prefrontal cortex of rodents. Front Neuroanat 2010;4:21. doi: 10.3389/fnana.2010.00021
   PubMedGoogle Scholar
• Beaulieu JM, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009;49:327–47
   PubMed Web of Science ®Google Scholar
• Aoyama S, Kase H, Borrelli E. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J Neurosci 2000;20:5848–52
   PubMed Web of Science ®Google Scholar
• Latapy C, Rioux V, Guitton MJ, Beaulieu JM. Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour. Philos Trans R Soc Lond B Biol Sci 2012;367:2460–74
   PubMed Web of Science ®Google Scholar
• Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron 2008;57:809–18
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Latapy C, Xu J, et al. Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways. Mol Psychiatry 2014;19:284–93
   PubMed Web of Science ®Google Scholar
• Kisilevsky AE, Zamponi GW. D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levels. Channels (Austin) 2008;2:269–77
   PubMed Web of Science ®Google Scholar